TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 52 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,342,000 | -43.5% | 665,900 | +1.0% | 0.05% | -27.9% |
Q4 2021 | $7,679,000 | -36.6% | 659,100 | +1.3% | 0.07% | -35.8% |
Q3 2021 | $12,114,000 | -16.4% | 650,600 | -4.8% | 0.11% | -10.9% |
Q2 2021 | $14,488,000 | +79.7% | 683,400 | +72.1% | 0.12% | +72.5% |
Q1 2021 | $8,063,000 | -28.4% | 397,200 | -6.4% | 0.07% | -24.2% |
Q4 2020 | $11,264,000 | +20.4% | 424,400 | +1.6% | 0.09% | +3.4% |
Q3 2020 | $9,356,000 | – | 417,700 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |